People and Business News — 5/22
People News
Rho has appointed Peter Schmidt, PhD, as Senior Vice President, Government Partnerships of Rho’s Federal Systems Division.
Syneos Health announced the promotions of Baba Shetty to President, Technology and Data Solutions, and Suma Ramadas to Executive Vice President, Medical Affairs.
Cytel Inc. has appointed Albert Kim, PhD, as its first Chief Medical Officer.
Greater Gift announces new board members, Clare Grace, Sharon Hanlon and Harsha Rajasimha.
HeartcoR Solutions announced that Dennis Bergau has joined the company as Vice President of Clinical Operations.
PHASTAR announced Ping-Chung Chang has joined the company as Head of China Development and Global Delivery.
Syneos Health announced the appointment of Michelle Keefe as CEO and a member of the Company’s Board of Directors.
Worldwide Clinical Trials announced Rosemarie Corrigan has joined the company as executive vice president, global quality.
physIQ announced the appointment of two new members to its executive leadership team. John Wilson has been named Senior Vice President and General Manager of Life Sciences, and Chris Englerth joins the team as Vice President of Marketing.
Business News
ActiGraph is the latest business to receive funding through the Industry Resilience and Diversification Fund.
Clinerion has received patent protection for their revolutionary ANID technology.
Emmes announced that it is providing data, statistical analysis, and project management support for new research that will test the Moderna mRNA vaccine at more than 50 sites in South and East Africa.
Clario announced the release of its first Environmental, Social and Governance Report.
Recognition
Northwestern University Feinberg School of Medicine Research Team:Robert F. Kushner, MD, Alicia Agnoli, MD, MPH, MHS, Lesley Inker, MD, and Chi-yuan Hsu, MD, MS
The Herbert Pardes Clinical Research Excellence Award, was given to a research team from Northwestern University Feinberg School of Medicine the study, Once-Weekly Semaglutide in Adults with Overweight or Obesity. Two additional Distinguished Clinical Research Achievement Awards (one shared) were presented for their creativity, innovation, and novel approach that demonstrated immediate impact on the health and well-being of patients to University of California, Davis and to Tufts University School of Medicine andUniversity of California San Francisco.
Rho was named the winner of a Silver Stevie Award in the Fastest Growing Company of the Year category in the 20th Annual American Business Awards.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
